Drug Interactions between Metoprolol Tartrate and pravastatin
This report displays the potential drug interactions for the following 2 drugs:
- Metoprolol Tartrate (metoprolol)
- pravastatin
Interactions between your drugs
No interactions were found between Metoprolol Tartrate and pravastatin. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
Metoprolol Tartrate
A total of 479 drugs are known to interact with Metoprolol Tartrate.
- Metoprolol tartrate is in the drug class cardioselective beta blockers.
- Metoprolol tartrate is used to treat the following conditions:
pravastatin
A total of 154 drugs are known to interact with pravastatin.
- Pravastatin is in the drug class statins.
-
Pravastatin is used to treat the following conditions:
- High Cholesterol
- High Cholesterol, Familial Heterozygous
- Hyperlipoproteinemia
- Hyperlipoproteinemia Type IIa, Elevated LDL
- Hyperlipoproteinemia Type IIb, Elevated LDL VLDL
- Hyperlipoproteinemia Type III, Elevated beta-VLDL IDL
- Hyperlipoproteinemia Type IV, Elevated VLDL
- Ischemic Stroke, Prophylaxis
- Myocardial Infarction, Prophylaxis
- Revascularization Procedures, Prophylaxis
Drug and food interactions
metoprolol food
Applies to: Metoprolol Tartrate (metoprolol)
Food can enhance the levels of metoprolol in your body. You should take metoprolol at the same time each day, preferably with or immediately following meals. This will make it easier for your body to absorb the medication. Avoid drinking alcohol, which could increase drowsiness and dizziness while you are taking metoprolol. Metoprolol is only part of a complete program of treatment that also includes diet, exercise, and weight control. Follow your diet, medication, and exercise routines very closely.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See Also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.